Top Wall Street analysts have made some notable changes to their outlook on certain companies. For a comprehensive overview of all analyst rating changes, including upgrades and downgrades, please refer to our analyst ratings page.
Morgan Stanley analyst Ronald Kamdem has raised the price target for Regency Centers Corporation (NASDAQ:REG) from $62 to $75. Additionally, Kamdem upgraded the stock from Equal-Weight to Overweight. Despite this positive news, Regency Centers shares experienced a slight decline of 1.3%, closing at $65.54 on Wednesday. To gain further insights into this stock, be sure to check out how other analysts view it.
Wedbush analyst Scott Devitt has increased the price target for Amazon.com, Inc. (NASDAQ:AMZN) from $180 to $210. Devitt has maintained an Outperform rating for the stock. However, Amazon shares saw a decrease of 1.1%, ending Wednesday at $152.12. To get a comprehensive understanding of this stock, take a look at how other analysts view it.
Wells Fargo analyst Derek Archila has lowered the price target for argenx SE (NASDAQ:ARGX) from $585 to $470. Nevertheless, Archila maintained an Overweight rating for the stock. Unfortunately, argenx shares experienced a significant drop of 25.1%, closing at $338.91 on Wednesday. To gain further insights into this stock, be sure to check out how other analysts view it.
Deutsche Bank analyst Sidney Ho has raised the price target for Micron Technology, Inc. (NASDAQ:MU) from $85 to $90. Ho has maintained a Buy rating for the stock. Despite this positive news, Micron shares saw a decline of 4.2%, closing at $78.69 on Wednesday. To get a comprehensive understanding of this stock, take a look at how other analysts view it.
HC Wainwright & Co. analyst Douglas Tsao has raised the price target for Immunovant, Inc. (NASDAQ:IMVT) from $47 to $51. Tsao has maintained a Buy rating for the stock. Unfortunately, Immunovant shares experienced a decline of 12.8%, closing at $36.18 on Wednesday. To gain further insights into this stock, be sure to check out how other analysts view it.
Needham analyst Alex Henderson has increased the price target for CrowdStrike Holdings, Inc. (NASDAQ:CRWD) from $250 to $325. Henderson has maintained a Buy rating for the stock. Despite this positive news, CrowdStrike shares saw a decline of 1.7%, closing at $253.95 on Wednesday. To get a comprehensive understanding of this stock, take a look at how other analysts view it.
Morgan Stanley analyst Keith Weiss has raised the price target for Salesforce, Inc. (NYSE:CRM) from $290 to $350. Additionally, Weiss upgraded the stock from Equal-Weight to Overweight. However, Salesforce shares experienced a decline of 1.6%, closing at $260.25 on Wednesday. To gain further insights into this stock, be sure to check out how other analysts view it.
Pivotal Research analyst Jeffrey Wlodarczak has raised the price target for Spotify Technology S.A. (NYSE:SPOT) from $170 to $265. Furthermore, Wlodarczak upgraded the stock from Hold to Buy. Unfortunately, Spotify shares saw a decline of 1.1%, closing at $188.71 on Wednesday. To get a comprehensive understanding of this stock, take a look at how other analysts view it.
Baird analyst Jeff Johnson has increased the price target for Insulet Corporation (NASDAQ:PODD) from $180 to $238. Additionally, Johnson upgraded the stock from Neutral to Outperform. Despite this positive news, Insulet shares saw a decline of 3.1%, closing at $207.97 on Wednesday. To gain further insights into this stock, be sure to check out how other analysts view it.
JP Morgan analyst Allen Gong has raised the price target for Glaukos Corporation (NYSE:GKOS) from $66 to $91. Gong has also upgraded the stock from Neutral to Overweight. Unfortunately, Glaukos shares experienced a decline of 2%, closing at $79.60 on Wednesday. To get a comprehensive understanding of this stock, take a look at how other analysts view it.
For more information, don’t miss out on our article titled “Micron, Carnival And 3 Stocks To Watch Heading Into Thursday.”